MARKET

BNGO

BNGO

Bionano Genomics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

9.84
+0.11
+1.13%
Pre Market: 9.77 -0.07 -0.71% 05:46 03/02 EST
OPEN
10.04
PREV CLOSE
9.73
HIGH
10.26
LOW
9.77
VOLUME
22.65K
TURNOVER
--
52 WEEK HIGH
15.69
52 WEEK LOW
0.2500
MARKET CAP
1.79B
P/E (TTM)
-13.1480
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Bionano Genomics, Inc. (BNGO) Gains But Lags Market: What You Should Know
Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading session, marking a +1.13% move from the prior day.
Zacks · 12h ago
Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and Cancer
GlobeNewswire · 21h ago
Bionano Genomics Highlights Publication In Science Journal Of A Study By Human Genome Structural Variation Consortium Using Co.'s Saphyr
Article published in Science reveals that optical genome mapping uniquely makes thousands of large structural variant calls SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) announced the
Benzinga · 4d ago
Bionano's Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed
SAN DIEGO, Feb 25, 2021 (GLOBE NEWSWIRE via COMTEX) -- SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the...
GlobeNewswire · 4d ago
Analyst Pounds the Table on Bionano (BNGO) Stock
There’s a lot of buzz around Bionano (BNGO) right now. Due to a growing interest in gene editing and the potential of its genome imaging system, Saphyr, the company has caught investors’ attention. Maxim analyst Jason McCarthy was an early champion of the ...
TipRanks · 4d ago
Are These Top Health Care Stocks Worth Watching Ahead Of March?
StockMarket.com · 4d ago
Thinking about buying stock in Nokia, BioNano Genomics, TJX Companies, Bank of America, or Advanced Micro Devices?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NOK, BNGO, TJX, BAC, and AMD.
PR Newswire - PRF · 6d ago
Analyzing Bionano Genomics's Unusual Options Activity
Benzinga · 6d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BNGO. Analyze the recent business situations of Bionano Genomics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BNGO stock price target is 10.94 with a high estimate of 15.00 and a low estimate of 0.7500.
EPS
Institutional Holdings
Institutions: 61
Institutional Holdings: 11.64M
% Owned: 6.41%
Shares Outstanding: 181.68M
TypeInstitutionsShares
Increased
7
2.05M
New
34
1.98M
Decreased
7
1.03M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+2.38%
Healthcare Equipment & Supplies
+2.12%
Key Executives
Chairman/Independent Director
David Barker
President/Chief Executive Officer/Director
R. Erik Holmlin
President/Chief Executive Officer/Director
R Holmlin
Chief Operating Officer
Mark Borodkin
Chief Financial Officer
Christopher Stewart
Chief Operating Officer
Mark Oldakowski
Other
Alka Chaubey
Director
Yvonne Linney
Director
Hannah Mamuszka
Independent Director
Albert Luderer
Independent Director
Christopher Twomey
Independent Director
Kristiina Vuori
  • Dividends
  • Splits
  • Insider Activity
No Data
About BNGO
Bionano Genomics, Inc. is a life sciences instrumentation company in the genome analysis space. The Company develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response. The Company’s subsidiary, Lineagen, Inc., provides molecular diagnostics services for individuals.

Webull offers kinds of BioNano Genomics Inc stock information, including NASDAQ:BNGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNGO stock methods without spending real money on the virtual paper trading platform.